Telix Pharmaceuticals Limited TLX
11.45
0.14
1.24%
as of 25 Sep
- Market cap
- $3.9B
- P/E
- —
Follow TLX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
5.85 | 0.00 | 0.00 |
EV/FCF |
32.89 | 0.00 | 0.00 |
Quick Ratio |
1.17 | 2.57 | 1.14 |
Current Ratio |
1.43 | 2.78 | 1.41 |
Net Debt/EBITDA |
6.25 | (1.35) | (4.71) |
Debt/Assets |
39.65% | 38.14% | 4.15% |
Debt/Equity |
1.11 | 1.02 | 0.11 |
Asset Turnover |
0.76 | 0.85 | 0.00 |
Operating CF/Net income |
2.43 | 0.82 | 4.58 |
Capex/Depreciation |
(2.04) | (4.20) | (1.60) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (1.85%) | 14.91% | 0.00% | |
| (0.68%) | 5.57% | 0.00% | |
ROIC |
2.53% | 12.70% | 23.28% |
Return on Tangible Assets |
(4.53%) | 8.57% | 5.75% |
Average Days of Receivables |
58.67 | 61.42 | 47.05 |
Research and Development Expense of Revenue |
21.31% | 24.77% | 25.58% |
Selling, General and Administrative Expense of Revenue |
29.50% | 30.58% | 26.70% |
Intangible Assets out of Total Assets |
0.51 | 0.27 | 0.27 |
Share Based Compensation of Revenue |
2.41% | 2.50% | 1.75% |
Graham Net Nets |
0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% |
Revenue per Share |
2.38 | 1.56 | 1.05 |
Operating CF per Share |
(0.05) | 0.08 | 0.05 |
Capex per Share |
(0.13) | (0.07) | (0.02) |
Free Cash Flow per Share |
(0.18) | 0.02 | 0.03 |
Cash per Share |
0.42 | 1.33 | 0.26 |
Shareholders Equity per Share |
1.23 | 1.07 | 0.31 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
1.23 | 1.07 | 0.31 |
Free Cash Flow |
(61.07) | 5.31 | 8.70 |
Working Capital |
98.66 | 365.03 | 44.81 |
Capital Expenditures |
(43.78) | (22.18) | (7.17) |
Net Current Asset Value |
(418.33) | (17.32) | (16.31) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.04 | 0.02 |
Net Profit Margin |
(0.89%) | 6.52% | 1.04% |
| Other line items | |||
Depreciation/Fixed assets |
0.37 | 0.19 | 0.29 |
Cash ROIC |
(7.46%) | (0.03%) | 0.25% |
Accounts Receivable Turnover |
7.44 | 7.95 | 0.00 |
Accounts Payable Turnover |
3.18 | 2.56 | 0.00 |
Inventory Turnover |
12.43 | 10.27 | 0.00 |
Average Days of Payables |
145.43 | 175.61 | 158.50 |
Days of Inventory on Hand |
35.87 | 47.79 | 33.58 |
Average Receivables |
108.07 | 64.98 | — |
Average Payables |
118.57 | 70.54 | — |
Average Inventory |
30.35 | 17.56 | — |
Average Assets |
1,052.18 | 605.05 | — |
Average Common Equity |
384.16 | 225.94 | — |
Columns are period end dates